cycloheximide has been researched along with Angiogenesis, Pathologic in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, YJ; Ge, ZZ; Liang, Q; Lin, XL; Tang, CT; Tang, MY; Wu, S; Zhang, QW | 1 |
| Huang, JJ; Shan, JZ; Xuan, YY; Zhang, Q | 1 |
| Bussolati, B; Buttiglieri, S; Camussi, G; Deregibus, MC; Russo, S | 1 |
| Handa, Y; Kubota, T; Matsukawa, S; Sato, K; Takeuchi, H; Yao, Y | 1 |
| Adatia, R; Albini, A; Benelli, R; Ensoli, B; Santi, L; Stetler-Stevenson, WG | 1 |
| Chen, JK; Kao, CH; Wang, DY; Yang, VC | 1 |
| Bar-Eli, M; Gutman, M; Reich, R; Singh, RK | 1 |
| Maciag, T; Villeponteau, B; Zimrin, AB | 1 |
| Adamis, AP; Amano, S; Beerepoot, LV; Colby, KA; Kim, RY; Kuroki, M; Rohan, RM; Takashima, S; Tolentino, M; Voest, EE; Yeo, KT | 1 |
| Alexander, HR; Berger, AC; Figg, WD; Grove, A; Hewitt, SM; Kohn, E; Kruger, E; Libutti, SK; Stern, D; Tang, G; Turner, E; Wu, PS | 1 |
10 other study(ies) available for cycloheximide and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Thalidomide targets EGFL6 to inhibit EGFL6/PAX6 axis-driven angiogenesis in small bowel vascular malformation.
Topics: Angiogenesis Inhibitors; Animals; Calcium-Binding Proteins; Cell Adhesion Molecules; Cycloheximide; Disease Models, Animal; Endothelial Cells; Gastrointestinal Tract; Gene Expression Regulation; Hemorrhage; Humans; Intestine, Small; Morphogenesis; Neovascularization, Pathologic; Peptide Hydrolases; Thalidomide; Vascular Malformations; Zebrafish; Zebrafish Proteins | 2020 |
Ursolic acid sensitized colon cancer cells to chemotherapy under hypoxia by inhibiting MDR1 through HIF-1α.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cycloheximide; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fluorouracil; Human Umbilical Vein Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Neovascularization, Pathologic; Organoplatinum Compounds; Oxaliplatin; Real-Time Polymerase Chain Reaction; RNA, Small Interfering; Triterpenes; Ursolic Acid; Vascular Endothelial Growth Factor A | 2016 |
CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis.
Topics: Androstadienes; Apoptosis; Blotting, Western; Bromodeoxyuridine; CD40 Antigens; CD40 Ligand; Cell Division; Cell Movement; Cell Survival; Cells, Cultured; Chromones; Cycloheximide; DNA Fragmentation; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Enzyme Inhibitors; Flow Cytometry; Humans; Morpholines; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Phosphorylation; Precipitin Tests; Protein Synthesis Inhibitors; Proteins; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-cbl; Signal Transduction; Time Factors; TNF Receptor-Associated Factor 6; Transfection; Ubiquitin-Protein Ligases; Wortmannin | 2003 |
Cell-specific but p53-independent regulation of vascular endothelial growth factor expression by interferons in human glioblastoma cells.
Topics: Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cycloheximide; Dactinomycin; Enzyme-Linked Immunosorbent Assay; Glioblastoma; Humans; Interferons; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Suppressor Protein p53; Up-Regulation; Vascular Endothelial Growth Factor A | 2006 |
Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy.
Topics: Acquired Immunodeficiency Syndrome; Amino Acid Sequence; Chemotaxis; Collagen; Culture Media, Conditioned; Cycloheximide; Drug Combinations; Endothelium, Vascular; Gelatinases; Gene Expression Regulation, Neoplastic; Humans; Intercellular Signaling Peptides and Proteins; Laminin; Matrix Metalloproteinase 2; Metalloendopeptidases; Molecular Sequence Data; Muscle, Smooth, Vascular; Neoplasm Invasiveness; Neoplasm Proteins; Neovascularization, Pathologic; Peptides; Proteins; Proteoglycans; Sarcoma, Kaposi; Tissue Inhibitor of Metalloproteinase-2; Tumor Cells, Cultured; Umbilical Veins | 1994 |
Glycosaminoglycans enhance phorbol ester-induced proteolytic activity and angiogenesis in vitro.
Topics: Cell Differentiation; Cells, Cultured; Chondroitin Sulfates; Cycloheximide; Drug Synergism; Endothelium, Vascular; Glycosaminoglycans; Humans; Hyaluronic Acid; Neovascularization, Pathologic; Peptide Hydrolases; Tetradecanoylphorbol Acetate | 1994 |
Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8.
Topics: Animals; Carrier Proteins; Collagenases; Cyclin-Dependent Kinase Inhibitor p16; Cycloheximide; Dose-Response Relationship, Radiation; Gene Expression Regulation, Neoplastic; Genes, p53; In Vitro Techniques; Interleukin-8; Lung Neoplasms; Male; Matrix Metalloproteinase 9; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; RNA, Messenger; Skin Neoplasms; Tumor Cells, Cultured; Ultraviolet Rays | 1995 |
Models of in vitro angiogenesis: endothelial cell differentiation on fibrin but not matrigel is transcriptionally dependent.
Topics: Base Sequence; Cell Differentiation; Cells, Cultured; Collagen; Culture Media; Cycloheximide; Dactinomycin; Drug Combinations; Endothelium, Vascular; Fibrin; Fibroblast Growth Factor 1; Humans; Laminin; Models, Biological; Molecular Sequence Data; Neovascularization, Pathologic; Proteoglycans; Transcription, Genetic; Umbilical Veins | 1995 |
Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo.
Topics: Animals; Antioxidants; Cattle; Cells, Cultured; Cycloheximide; Dactinomycin; Endothelial Growth Factors; Enzyme Inhibitors; Gene Expression Regulation, Developmental; Glioblastoma; Half-Life; Humans; Hydrogen Peroxide; Lymphokines; Melanoma; Neovascularization, Pathologic; Neovascularization, Physiologic; Oxygen; Pigment Epithelium of Eye; Rabbits; Rats; Reactive Oxygen Species; Reperfusion; Retina; RNA, Messenger; Superoxides; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1996 |
Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
Topics: 3T3 Cells; Angiogenesis Inhibitors; Animals; Aorta; Apoptosis; Arabidopsis Proteins; Cell Division; Cycloheximide; Cytokines; Endothelium, Vascular; Fatty Acid Desaturases; Female; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Lipopolysaccharides; Lung; Melanoma; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Neovascularization, Pathologic; Proto-Oncogene Proteins c-bcl-2; Rats; Recombinant Fusion Proteins; RNA-Binding Proteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Umbilical Veins | 2000 |